Homeostatic control of regulatory T cell diversity

Nature Reviews Immunology

Volumn 14, Issue 3, 2014, Pages 154-165

  Liston, Adrian ^a,b   Gray, Daniel H D ^c,d  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; CD40 LIGAND; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR5; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INDUCIBLE T CELL COSTIMULATOR; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 27; INTERLEUKIN 6; INTERLEUKIN 7; LIPID; LONG CHAIN FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN BCL 6; SHORT CHAIN FATTY ACID; STAT3 PROTEIN; STAT5 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR T BET;

ADAPTATION; ADIPOSE TISSUE; APOPTOSIS; CD4+ CD25+ T LYMPHOCYTE; CELL HETEROGENEITY; CYTOKINE PRODUCTION; DERMATITIS; EFFECTOR CELL; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; HOMEOSTASIS; HUMAN; IMMUNE DYSREGULATION; IMMUNOREGULATION; INFLAMMATION; INTRAABDOMINAL FAT; KILLER CELL; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; STEADY STATE; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION; TUBERCULOSIS;

ANIMALS; APOPTOSIS; CELL DIVISION; CELL PROLIFERATION; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; HOMEOSTASIS; HUMANS; INFLAMMATION; MICE; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTION, GENETIC;

EID: 84896704750     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3605     Document Type: Review

References (121)

1. Liston, A. & Piccirillo, C. A. Developmental plasticity of murine and human Foxp3+ regulatory T cells. Adv. Immunol. 119, 85-106 (2013).
2. Hsieh, C. S., Lee, H. M. & Lio, C. W. Selection of regulatory T cells in the thymus. Nature Rev. Immunol. 12, 157-167 (2012).
3. Paiva, R. S. et al. Recent thymic emigrants are the preferential precursors of regulatory T cells differentiated in the periphery. Proc. Natl Acad. Sci. USA 110, 6494-6499 (2013).
4. Mabarrack, N. H., Turner, N. L. & Mayrhofer, G. Recent thymic origin, differentiation, and turnover of regulatory T cells. J. Leukocyte Biol. 84, 1287-1297 (2008).
5. Atarashi, K. et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232-236 (2013).
6. Samstein, R. M. et al. Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell 150, 29-38 (2012).
7. Josefowicz, S. Z. et al. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 482, 395-399 (2012).
8. Thornton, A. M. et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J. Immunol. 184, 3433-3441 (2010).
9. Weiss, J. M. et al. Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J. Exp. Med. 209, 1723-1742 (2012).
10. Yadav, M. et al. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J. Exp. Med. 209, 1713-1722 (2012).
11. Williams, L. M. & Rudensky, A. Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nature Immunol. 8, 277-284 (2007).
12. Fu, W. et al. A multiply redundant genetic switch locks in the transcriptional signature of regulatory T cells. Nature Immunol. 13, 972-980 (2012).
13. Rudra, D. et al. Transcription factor Foxp3 and its protein partners form a complex regulatory network. Nature Immunol. 13, 1010-1019 (2012).
14. Kitoh, A. et al. Indispensable role of the Runx1-Cbf? transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells. Immunity 31, 609-620 (2009).
15. Rubtsov, Y. P. et al. Stability of the regulatory T cell lineage in vivo. Science 329, 1667-1671 (2010).
16. Campbell, D. J. & Koch, M. A. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nature Rev. Immunol. 11, 119-130 (2011).
17. Lee, J. H., Kang, S. G. & Kim, C. H. FoxP3+ T cells undergo conventional first switch to lymphoid tissue homing receptors in thymus but accelerated second switch to nonlymphoid tissue homing receptors in secondary lymphoid tissues. J. Immunol. 178, 301-311 (2007).
18. Kleinewietfeld, M. et al. CCR6 expression defines regulatory effector/memory-like cells within the CD25+CD4+ T-cell subset. Blood 105, 2877-2886 (2005).
19. Huehn, J. et al. Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J. Exp. Med. 199, 303-313 (2004).
20. Suffia, I., Reckling, S. K., Salay, G. & Belkaid, Y. A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection. J. Immunol. 174, 5444-5455 (2005).
21. Stephens, G. L., Andersson, J. & Shevach, E. M. Distinct subsets of FoxP3+ regulatory T cells participate in the control of immune responses. J. Immunol. 178, 6901-6911 (2007).
22. Beyersdorf, N., Ding, X., Tietze, J. K. & Hanke, T. Characterization of mouse CD4 T cell subsets defined by expression of KLRG1. Eur. J. Immunol. 37, 3445-3454 (2007).
23. Feuerer, M. et al. Genomic definition of multiple ex vivo regulatory T cell subphenotypes. Proc. Natl Acad. Sci. USA 107, 5919-5924 (2010).
24. Miyara, M. et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30, 899-911 (2009).
25. Sather, B. D. et al. Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory disease. J. Exp. Med. 204, 1335-1347 (2007).
26. Sanchez, A. M., Zhu, J., Huang, X. & Yang, Y. The development and function of memory regulatory T cells after acute viral infections. J. Immunol. 189, 2805-2814 (2012).
27. Rosenblum, M. D. et al. Response to self antigen imprints regulatory memory in tissues. Nature 480, 538-542 (2011).
28. Brincks, E. L. et al. Antigen-specific memory regulatory CD4+Foxp3+ T cells control memory responses to influenza virus infection. J. Immunol. 190, 3438-3446 (2013).
29. Webster, K. E. et al. In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J. Exp. Med. 206, 751-760 (2009).
30. Cheng, G., Yu, A., Dee, M. J. & Malek, T. R. IL-2R signaling is essential for functional maturation of regulatory T cells during thymic development. J. Immunol. 190, 1567-1575 (2013).
31. Yu, A., Zhu, L., Altman, N. H. & Malek, T. R. A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells. Immunity 30, 204-217 (2009).
32. Cretney, E. et al. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nature Immunol. 12, 304-311 (2011).
33. Cretney, E., Kallies, A. & Nutt, S. L. Differentiation and function of Foxp3+ effector regulatory T cells. Trends Immunol. 34, 74-80 (2013).
34. Martinez, G. J. & Rao, A. Immunology. Cooperative transcription factor complexes in control. Science 338, 891-892 (2012).
35. Koch, M. A. et al. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nature Immunol. 10, 595-602 (2009).
36. Wohlfert, E. A. et al. GATA3 controls Foxp3+ regulatory T cell fate during inflammation in mice. J. Clin. Invest. 121, 4503-4515 (2011).
37. Chaudhry, A. et al. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326, 986-991 (2009).
38. Linterman, M. A. et al. Foxp3+ follicular regulatory T cells control the germinal center response. Nature Med. 17, 975-982 (2011).
39. Chung, Y. et al. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nature Med. 17, 983-988 (2011).
40. Wollenberg, I. et al. Regulation of the germinal center reaction by Foxp3+ follicular regulatory T cells. J. Immunol. 187, 4553-4560 (2011).
41. Chaudhry, A. & Rudensky, A. Y. Control of inflammation by integration of environmental cues by regulatory T cells. J. Clin. Invest. 123, 939-944 (2013).
42. Josefowicz, S. Z., Lu, L. F. & Rudensky, A. Y. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30, 531-564 (2012).
43. Wang, Y., Su, M. A. & Wan, Y. Y. An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity 35, 337-348 (2011).
44. Tian, L., Humblet-Baron, S. & Liston, A. Immune tolerance: are regulatory T cell subsets needed to explain suppression of autoimmunity? BioEssays 34, 569-575 (2012).
45. Tian, L. et al. Foxp3+ regulatory T cells exert asymmetric control over murine helper responses by inducing Th2 cell apoptosis. Blood 118, 1845-1853 (2011).
46. Burzyn, D., Benoist, C. & Mathis, D. Regulatory T cells in nonlymphoid tissues. Nature Immunol. 14, 1007-1013 (2013).
47. Littman, D. R. & Rudensky, A. Y. Th17 and regulatory T cells in mediating and restraining inflammation. Cell 140, 845-858 (2010).
48. Round, J. L. & Mazmanian, S. K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl Acad. Sci. USA 107, 12204-12209 (2010).
49. Atarashi, K. et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337-341 (2011).
50. Geuking, M. B. et al. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 34, 794-806 (2011).
51. Russell, S. L. et al. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep. 13, 440-447 (2012).
52. Smith, P. M. et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569-573 (2013).
53. Feuerer, M. et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nature Med. 15, 930-939 (2009).
54. Cipolletta, D. et al. PPAR-? is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature. 486:549-553(2012).
55. Deiuliis, J. et al. Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers. PLoS ONE 6, e16376 (2011).
56. Shoelson, S. E., Lee, J. & Goldfine, A. B. Inflammation and insulin resistance. J. Clin. Invest. 116, 1793-1801 (2006).
57. Pierson, W. et al. Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3 regulatory T cells. Nature Immunol. 14, 959-965 (2013).
58. Vukmanovic-Stejic, M. et al. Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J. Clin. Invest. 116, 2423-2433 (2006).
59. Siggs, O. M. et al. Opposing functions of the T cell receptor kinase ZAP-70 in immunity and tolerance differentially titrate in response to nucleotide substitutions. Immunity 27, 912-926 (2007).
60. Shen, S. et al. The importance of LAT in the activation, homeostasis, and regulatory function of T cells. J. Biol. Chem. 285, 35393-35405 (2010).
61. Gogishvili, T. et al. Cell-intrinsic and -extrinsic control of Treg-cell homeostasis and function revealed by induced CD28 deletion. Eur. J. Immunol. 43, 188-193 (2013).
62. Tai, X. et al. Foxp3 transcription factor is proapoptotic and lethal to developing regulatory T cells unless counterbalanced by cytokine survival signals. Immunity 38, 1116-1128 (2013).
63. Miyazaki, K. et al. The role of the basic helix-loop-helix transcription factor Dec1 in the regulatory T cells. J. Immunol. 185, 7330-7339 (2010).
64. Ono, M. et al. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 446, 685-689 (2007).
65. Wu, Y. et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126, 375-387 (2006).
66. Thornton, A. M. & Shevach, E. M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287-296 (1998).
67. Vaeth, M. et al. Regulatory T cells facilitate the nuclear accumulation of inducible cAMP early repressor (ICER) and suppress nuclear factor of activated T cell c1 (NFATc1). Proc. Natl Acad. Sci. USA 108, 2480-2485 (2011).
68. Almeida, A. R., Zaragoza, B. & Freitas, A. A. Indexation as a novel mechanism of lymphocyte homeostasis: the number of CD4+CD25+ regulatory T cells is indexed to the number of IL-2-producing cells. J. Immunol. 177, 192-200 (2006).
69. Amado, I. F. et al. Quorum sensing in CD4+ T cell homeostasis: IL-2 coordinates IL-2 producing and regulatory T cell interplay. J. Exp. Med. 210, 2707-2720 (2013).
70. Guy, C. S. et al. Distinct TCR signaling pathways drive proliferation and cytokine production in T cells. Nature Immunol. 14, 262-270 (2013).
71. Zeng, H. et al. mTORC1 couples immune signals and metabolic programming to establish Treg-cell function. Nature 499, 485-490 (2013).
72. Chen, Q. et al. IL-2 controls the stability of Foxp3 expression in TGF-?-induced Foxp3+ T cells in vivo. J. Immunol. 186, 6329-6337 (2011).
73. Suffner, J. et al. Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3. LuciDTR mice. J. Immunol. 184, 1810-1820 (2010).
74. Delgoffe, G. M. et al. Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis. Nature 501, 252-256 (2013).
75. Carrette, F. & Surh, C. D. IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis. Semin. Immunol. 24, 209-217 (2012).
76. Dummer, W. et al. Autologous regulation of naive T cell homeostasis within the T cell compartment. J. Immunol. 166, 2460-2468 (2001).
77. Walker, L. S. Treg and CTLA-4: two intertwining pathways to immune tolerance. J. Autoimmun. 45, 49-57 (2013).
78. Benson, A. et al. Microbial infection-induced expansion of effector T cells overcomes the suppressive effects of regulatory T cells via an IL-2 deprivation mechanism. J. Immunol. 188, 800-810 (2012).
79. Oldenhove, G. et al. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31, 772-786 (2009).
80. Gratz, I. K. et al. Cutting edge: memory regulatory T cells require IL-7 and not IL-2 for their maintenance in peripheral tissues. J. Immunol. 190, 4483-4487 (2013).
81. Raynor, J. et al. IL-15 fosters age-driven regulatory T cell accrual in the face of declining IL-2 levels. Frontiers Immunol. 4, 161 (2013).
82. Sadlack, B. et al. Generalized autoimmune disease in interleukin-2- deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur. J. Immunol. 25, 3053-3059 (1995).
83. Schorle, H. et al. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352, 621-624 (1991).
84. Wolf, M., Schimpl, A. & Hunig, T. Control of T cell hyperactivation in IL-2-deficient mice by CD4+CD25- and CD4+CD25+ T cells: evidence for two distinct regulatory mechanisms. Eur. J. Immunol. 31, 1637-1645 (2001).
85. Willerford, D. M. et al. Interleukin-2 receptor ?chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3, 521-530 (1995).
86. Malek, T. R. et al. Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors. J. Immunol. 164, 2905-2914 (2000).
87. Suzuki, H. et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor ?. Science 268, 1472-1476 (1995).
88. Burchill, M. A. et al. IL-2 receptor ?-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J. Immunol. 178, 280-290 (2007).
89. Snow, J. W. et al. Loss of tolerance and autoimmunity affecting multiple organs in STAT5A/5B-deficient mice. J. Immunol. 171, 5042-5050 (2003).
90. Sharfe, N., Dadi, H. K., Shahar, M. & Roifman, C. M. Human immune disorder arising from mutation of the ? chain of the interleukin-2 receptor. Proc. Natl Acad. Sci. USA 94, 3168-3171 (1997).
91. Roifman, C. M. Human IL-2 receptor ? chain deficiency. Pediatr. Res. 48, 6-11 (2000).
92. Cohen, A. C. et al. Cutting edge: Decreased accumulation and regulatory function of CD4+ CD25high T cells in human STAT5b deficiency. J. Immunol. 177, 2770-2774 (2006).
93. Yamanouchi, J. et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nature Genet. 39, 329-337 (2007).
94. Lowe, C. E. et al. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nature Genet. 39, 1074-1082 (2007).
95. The International Consortium for Systemic Lupus Erythematosus Genetics et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nature Genet. 40, 204-210 (2008).
96. Blazar, B. R., Murphy, W. J. & Abedi, M. Advances in graft-versus-host disease biology and therapy. Nature Rev. Immunol. 12, 443-458 (2012).
97. Gaidot, A. et al. Immune reconstitution is preserved in hematopoietic stem cell transplantation coadministered with regulatory T cells for GVHD prevention. Blood 117, 2975-2983 (2011).
98. Wysocki, C. A. et al. Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease. Blood 106, 3300-3307 (2005).
99. Safinia, N. et al. Promoting transplantation tolerance; adoptive regulatory T cell therapy. Clin. Exp. Immunol. 172, 158-168 (2013).
100. Edinger, M. et al. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nature Med. 9, 1144-1150 (2003).
101. Shin, H. J. et al. Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells. Blood 118, 2342-2350 (2011).
102. Prinz, I. & Koenecke, C. Therapeutic potential of induced and natural FoxP3+ regulatory T cells for the treatment of graft-versus-host disease. Arch. Immunol. Ther. Exp. (Warsz) 60, 183-190 (2012).
103. Mielke, S. et al. Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease. Blood 110, 1689-1697 (2007).
104. Magenau, J. M. et al. Frequency of CD4+CD25hiFOXP3+ regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease. Biol. Blood Marrow Transplant. 16, 907-914 (2010).
105. Ukena, S. N. et al. Human regulatory T cells in allogeneic stem cell transplantation. Blood 118, e82-e92 (2011).
106. Ukena, S. N. et al. Acute but not chronic graft-versus-host disease is associated with a reduction of circulating CD4+CD25highCD127low/- regulatory T cells. Ann. Hematol. 90, 213-218 (2011).
107. Brunstein, C. G. et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 117, 1061-1070 (2011).
108. Di Ianni, M. et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 117, 3921-3928 (2011).
109. Koreth, J. et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. New Engl. J. Med. 365, 2055-2066 (2011).
110. Matsuoka, K. et al. Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease. Sci. Transl. Med. 5, 179ra143 (2013).
111. Barthlott, T. et al. CD25+ CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production. Int. Immunol. 17, 279-288 (2005).
112. Sitrin, J. et al. Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2. J. Exp. Med. 210, 1153-1165 (2013).
113. Franceschini, D. et al. PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. J. Clin. Invest. 119, 551-564 (2009).
114. Dupont, C. D., Christian, D. A. & Hunter, C. A. Immune response and immunopathology during toxoplasmosis. Semin. Immunopathol. 34, 793-813 (2012).
115. Wojno, E. D. et al. A role for IL-27 in limiting T regulatory cell populations. J. Immunol. 187, 266-273 (2011).
116. Quintana, F. J. et al. Aiolos promotes TH17 differentiation by directly silencing IL2 expression. Nature Immunol. 13, 770-777 (2012).
117. Venet, F. et al. Regulatory T cell populations in sepsis and trauma. J. Leukocyte Biol. 83, 523-535 (2008).
118. Cavassani, K. A. et al. The post sepsis-induced expansion and enhanced function of regulatory T cells create an environment to potentiate tumor growth. Blood 115, 4403-4411 (2010).
119. Venet, F. et al. Increased circulating regulatory T cells (CD4+CD25+CD127-) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med. 35, 678-686 (2009).
120. Ono, S. et al. Removal of increased circulating CD4+CD25+Foxp3+ regulatory T cells in patients with septic shock using hemoperfusion with polymyxin B-immobilized fibers. Surgery 153, 262-271 (2013).
121. Burzyn, D. et al. A special population of regulatory T cells potentiates muscle repair. Cell 155, 1282-1295 (2013).